ArticleJournal of proteome research2025

TRMU Confers Resistance of Melanoma Cells to Vemurafenib through Modulating Mitochondrial Activities.

Shiyuan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.